聯合利華拒上調對葛蘭素史克消費者健康護理業務建議收購價
英國消費品牌巨擘聯合利華(Unilever)表示,不會再上調對葛蘭素史克消費者健康護理業務的50億英鎊建議收購價,意味聯合利華放棄有關收購。
葛蘭素史克早前拒絕聯合利華的收購建議,認爲基本地低估有關業務的價值,並按計劃於年中分拆有關業務上市。公司表示將集中最大化股東價值,對未來業務及潛力非常有信心。
葛蘭素史克消費者健康護理業務包括舒適達牙膏、Emergen-C維他命產品及必利痛止痛藥。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.